NEW
YORK, July 8, 2024 /PRNewswire/ --The
global glycobiology market size is estimated to grow by
USD 2.21 billion from 2024-2028,
according to Technavio. The market is estimated to grow at a CAGR
of 18.52% during the forecast period. Growing prevalence of
cancer is driving market growth, with a trend
towards advancements in field of glycobiology.
However, complex structure of glycansis poses a challenge. Key
market players include Agilent Technologies Inc., Asparia
Glycomics, Bio Techne Corp., Bruker Corp., CD BioGlyco, Chemily
Glycoscience, Genovis AB, ICE S.p.a., Lectenz Bio, Ludger Ltd.,
Merck KGaA, New England Biolabs Inc., NZYTech, Plexera LLC,
Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio Inc., Thermo
Fisher Scientific Inc., Waters Corp., and ZBiotech.
Get a detailed analysis on regions, market
segments, customer landscape, and companies - Click for the
snapshot of this report
Forecast
period
|
2024-2028
|
Base Year
|
2023
|
Historic
Data
|
2018 - 2022
|
Segment
Covered
|
Application (Drug
discovery and development, Disease diagnostics, and Others),
Product (Enzymes, Instruments, Reagents, and Kits), and Geography
(North America, Europe, Asia, and Rest of World (ROW))
|
Region
Covered
|
North America, Europe,
Asia, and Rest of World (ROW)
|
Key companies
profiled
|
Agilent Technologies
Inc., Asparia Glycomics, Bio Techne Corp., Bruker Corp., CD
BioGlyco, Chemily Glycoscience, Genovis AB, ICE S.p.a., Lectenz
Bio, Ludger Ltd., Merck KGaA, New England Biolabs Inc., NZYTech,
Plexera LLC, Shimadzu Corp., Sumitomo Bakelite Co. Ltd., Takara Bio
Inc., Thermo Fisher Scientific Inc., Waters Corp., and
ZBiotech
|
Key Market Trends Fueling Growth
Glycobiology, the study of carbohydrates in biology, requires
advanced analytical methods to understand the functionally
important structural features of glycosylated biomolecules. Mass
Spectrometry (MS), with its various ionization techniques, MS, and
detection strategies, has emerged as the primary analytical
approach in glycomics and glycoproteomics research. Additionally,
microscale separation techniques such as Capillary Chromatography
and Electrophoresis, and carbohydrate microchemistry, have gained
significance. Advances in glycobiological techniques have led to
the identification of congenital glycosylation disorders (CDGs)
caused by defects in N-linked and O-linked glycosylation of
proteins. New technologies like glycan mimetics, glycan arrays,
metabolic intermediate glycan engineering, and glycan therapy have
enabled glycan-based clinical trials for various diseases.
Carbohydrate inefficiency due to inadequate immune response is
addressed by using carrier peptides like KLH, 2BSA, TT, CRM197, and
Gold Nanoparticles (AuNP) with carbohydrates, which are joined to
antigens inducing a strong T cell response and presentation to
Major Histocompatibility Complex (MHC) molecules. These
advancements in glycobiology are expanding the application of
glycans, thereby driving the growth of the global glycobiology
market.
The Glycobiology Market is experiencing significant growth due
to the increasing focus on glycans and their role in various
biological processes. Glycans, or complex carbohydrates, play a
crucial part in cell recognition, communication, and disease
progression. Glycan-binding proteins, glycan antigens, anti-glycan
antibodies, lectin inhibitors, polysaccharides, glycosidase
inhibitors, and glycosides are key areas of interest. Chronic
diseases like diabetes, cancer, and viral infections are driving
research and development in this field. Hyaluronan and
glycosaminoglycans are gaining attention in nanomedicine for glycan
nanostructures, drug delivery systems, and vaccine development.
Corporate expansion by biotechnology, pharmaceutical firms, and
CROs is fueling the market. High-Performance Liquid Chromatography
(HPLC), Mass Spectrometry (MS), and Capillary Electrophoresis (CE)
are essential technologies for glycomics research. Immunology,
diagnostics, oncology, and clinical trials are major application
areas. Merck and other leading firms are investing heavily in this
space. The rising analysis spending by administration groups and
the growing proteomics examination learnings and glycomics research
efforts are expected to boost Proteomics sales.
Discover 360° analysis of this market. For
complete information, schedule your consultation- Book
Here!
Market Challenges
- The glycobiology market faces challenges due to the
complex structure of glycans, which consist of monosaccharide
residues, glycosidic bonds, and non-glycan units. Different glycans
can bind to various parts of glycoproteins, and glycan-binding
proteins recognize three-dimensional features or specific surface
distributions. Carbohydrates, unlike proteins and nucleic acids,
form non-linear polymers with a distribution of conformational
states. Glycan characterization relies on methods like NMR
spectroscopy and molecular dynamics simulations due to glycans'
resistance to crystallization. The biological significance of
carbohydrate-protein interactions in development and disease is a
growing area of research. Protein glycosylation impacts protein
function and immunogenicity, making carbohydrate modeling crucial.
Glycan structural properties include monosaccharide composition,
sequence, and binding type. Despite the availability of crystal
structures for some monosaccharides and oligosaccharides, the
inherent flexibility of glycosidic bonds limits the growth of the
glycobiology market.
- The glycobiology market is experiencing significant growth
due to the increasing importance of carbohydrates in various
industries. This includes nanomedicine, where glycan nanostructures
play a crucial role in drug delivery and vaccine development.
Molecular diagnosis and antiviral therapeutics are also benefiting
from advances in glycobiology, as the technology aids in
identifying specific glycan markers for disease detection and
treatment. Pharmaceutical and biotechnology firms are expanding
their glycomics research efforts to develop new biomolecular
therapeutics and treatment drugs for conditions such as diabetes
and obesity. High-performance Liquid Chromatography (HPLC), Mass
Spectrometry (MS), and Capillary Electrophoresis (CE) are key
technologies driving research in this field. Corporate expansion,
rising analysis spending, and clinical trials in immunology,
oncology, and diagnostics are also contributing to the market's
growth. Companies like Merck are investing heavily in glycobiology
to stay competitive in the industry. Proteomics examination
learnings and the global glycomics market are also expected to
influence the development of the proteomics sector. The diagnostic
industry is also expected to benefit from the advancements in
glycobiology. The use of glycobiology in the development of
Hydroxychloroquine and other treatment drugs highlights its
potential in the healthcare sector. Administration groups are
closely monitoring the market trends and investing in glycobiology
to stay ahead of the competition.
For more insights on driver and
challenges - Download a Sample Report
Segment Overview
This glycobiology market report extensively covers market
segmentation by
- Application
- 1.1 Drug discovery and development
- 1.2 Disease diagnostics
- 1.3 Others
- Product
- 2.1 Enzymes
- 2.2 Instruments
- 2.3 Reagents
- 2.4 Kits
- Geography
- 3.1 North America
- 3.2 Europe
- 3.3 Asia
- 3.4 Rest of World (ROW)
1.1 Drug discovery and development- Glycobiology is a
crucial field in biology, primarily used for drug discovery and
development. Glycans, simple monosaccharides or complex structures,
play essential roles in various biological processes. They act as
abundant molecules in the body, an energy source, or structural
components. Complex glycans are vital for protein folding and
stability, solubility, and transport. Carbohydrates are found on
cell surfaces, influencing important functions through specific
glycan recognition. The glycosylation process is complex, varying
from cell to tissue, and is affected by the microenvironment.
Advances in glycan synthesis and analytical tools expand our
understanding of glycan-function relationships. New monosaccharides
binding to non-template-driven glycan biosynthesis broaden the
range of glycan structures. Increasing chronic and acute diseases
necessitate drug discovery, driving growth in the glycobiology
market's diagnostic segment.
For more information on market segmentation with geographical
analysis including forecast (2024-2028) and historic data (2018 -
2022) - Download a Sample Report
Research Analysis
The Glycobiology Market encompasses the production, research,
and application of glycans, which are complex carbohydrate
structures found on the surface of living things. Glycans play
essential roles in various biological processes, including cell
recognition, immune response, and disease progression.
Glycan-binding proteins, such as lectins and anti-glycan
antibodies, interact with these structures, making them valuable
tools in glycobiology research. Polysaccharides, glycosides,
glycosidase inhibitors, and lectin inhibitors are key components of
this field. Glycobiology's advancements are driven by technology
innovations, including High-Performance Liquid Chromatography
(HPLC), Mass Spectrometry (MS), and Capillary Electrophoresis (CE),
provided by companies like Agilent Technologies. Corporate
expansion, rising analysis spending, administration groups,
biotechnology firms, and pharmaceutical firms are investing in
glycomics research efforts to better understand the functions of
glycans and develop new therapeutics. Proteomics examination
learnings contribute to the growing importance of glycobiology in
understanding the complex interplay between carbohydrates and
proteins.
Market Research Overview
The glycobiology market encompasses the study of glycans,
complex carbohydrate structures found on the surfaces of living
organisms. Glycans play crucial roles in various biological
processes, including cell recognition, signaling, and disease
progression. Glycan-binding proteins, glycan antigens, anti-glycan
antibodies, lectin inhibitors, glycosidase inhibitors, glycosides,
and polysaccharides are key components of this field. Glycomes and
proteomes are essential tools for understanding glycan functions in
health and disease. Chronic diseases, such as diabetes and obesity,
are major targets for glycobiology research in drug development.
Technologies like High-Performance Liquid Chromatography (HPLC),
Mass Spectrometry (MS), and Capillary Electrophoresis (CE) are used
for glycan analysis. The market is driven by rising analysis
spending, corporate expansion, and glycomics research efforts in
biotechnology and pharmaceutical firms. Applications include
nanomedicine, molecular diagnosis, antiviral therapeutics, vaccine
development, and drug delivery systems. Hydroxychloroquine, a
treatment drug, is an example of a glycoside used in therapy. The
global glycomics market is expected to grow significantly due to
increasing healthcare spending and the diagnostic industry's focus
on precision medicine.
Table of Contents:
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation
- Application
-
- Drug Discovery And Development
- Disease Diagnostics
- Others
- Product
-
- Enzymes
- Instruments
- Reagents
- Kits
- Geography
-
- North America
- Europe
- Asia
- Rest Of World (ROW)
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix
About Technavio
Technavio is a leading global technology research and advisory
company. Their research and analysis focuses on emerging market
trends and provides actionable insights to help businesses identify
market opportunities and develop effective strategies to optimize
their market positions.
With over 500 specialized analysts, Technavio's report library
consists of more than 17,000 reports and counting, covering 800
technologies, spanning across 50 countries. Their client base
consists of enterprises of all sizes, including more than 100
Fortune 500 companies. This growing client base relies on
Technavio's comprehensive coverage, extensive research, and
actionable market insights to identify opportunities in existing
and potential markets and assess their competitive positions within
changing market scenarios.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
View original content to download
multimedia:https://www.prnewswire.com/news-releases/glycobiology-market-size-is-set-to-grow-by-usd-2-21-billion-from-2024-2028--growing-prevalence-of-cancer-to-boost-the-market-growth-technavio-302189624.html
SOURCE Technavio